Skip to main content
OpenTrials

Clinical trial condition

Recurrent Grade 3 Follicular Lymphoma

Explore clinical trials studying Recurrent Grade 3 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

99 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Grade 3 Follicular Lymphoma trial results

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

NCT00343798

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Colorado Denver, Colorado, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms

NCT00082784

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details

Related conditions